Gary W. Herschman, Anjana D. Patel, and Timothy (Tim) C. McHale, attorneys in the Health Care & Life Sciences practice, in the firm’s Newark office, were quoted in Bloomberg Health Law & Life Sciences, in “Health-Care Deals Stay on Pace Despite Rising Interest Rates” by Christopher Brown.

Following is an excerpt:

Health-care mergers and acquisitions continued at a steady pace in April in the face of rising interest rates and ongoing uncertainty from the Russian invasion of Ukraine.

The total number of transactions for the month was 176, up slightly from 174 in March, but down from 207 deals in April 2021. …

Devices, Physician Practices …

Activity in the physician group sector continues to be strong and appears likely to continue at a brisk pace, according to health-care investment bankers and attorneys, said Gary Herschman of Epstein, Becker & Green PC in Newark.

The first four months of 2022 saw deals in the double digits in several physician-practice subsectors, including primary care, eye care, and dermatology.

Others showing steady activity include gastroenterology; orthopedics; women’s care; ear, nose and throat practices; and podiatry, Herschman said.

“Experts are expecting a big uptick in the volume of orthopedic group deals throughout the year,” Herschman said. “Further, consolidation of cardiology groups is starting to ramp up, with this subsector expected to see growing volume throughout the year.” …

Health IT

Activity in the health-care IT sector sends a strong signal that telemedicine initiatives are becoming a permanent solution across many care settings, said Anjana Patel of Epstein Becker & Green.

One example was the announced transaction between United Wound and Skin Solutions LLC, a provider of virtual health services, and Precision Healing Inc., a health-care technology company with a diagnostic platform for wound healing, she said.

April was also a solid month for cannabis transactions, as the sector extended its streak to 16 consecutive months of producing double-digit deal volume, said Timothy McHale of Epstein Becker & Green.

Deals took place in 10 different states, including Texas and Wyoming, and across the full spectrum of services, including therapeutics, cultivation, manufacturing, and dispensing, he said.

Epstein Becker Green and KPMG did not comment on any particular transaction or party discussed or listed in this article.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.